FDA agreed that data from the Phase 2a diSArm study support advancement of AP-SA02 to a Phase 3study First bacteriophage company to advance a clinical candidate to ...

Armata Pharmaceuticals, Inc. ("Armata" or the "Company"), a late clinical-stage biotechnology company focused on the development of high-purity, pathogen-specific bacteriophage therapeutics for the ...

Select gut bacteria protect mice against post-influenza virus secondary bacterial pneumonia, according to a study published ...

People who persistently carry Staphylococcus aureus (S. aureus) in their nose have fewer species of other bacteria, while certain bacteria may help to prevent S. aureus colonization. These are the ...

INTRODUCTION: In venous ulcers, the presence of Staphylococcus aureus and coagulase-negative staphylococcus resistance phenotypes can aggravate and limit the choices for treatment. METHODS: ...

Bacteriophages, or phages, are viruses that can selectively target and kill bacteria. Credit: nobeastsofierce via Shutterstock.com. At IDWeek 2025, held on 19–22 October, Dr Loren Miller from ...

Baby Sophia Smith died at the Royal Hospital for Children at the Queen Elizabeth University Hospital Campus, Glasgow on 11 April 2017. In her determination, Sheriff Joanna McDonald made formal ...

A) Growth curves and B) total growth of ancestral MRSA and MSSA populations in vitro with and without sub-MIC oxacillin. Different letters indicate significant differences. C) MRSA and MSSA were ...

Staphylococcus aureus (S. aureus) is one of the most frequent causes of hospital acquired infections. With the increase in multiple drug resistant strains, natural products such as propolis are a ...

In this randomized trial, dalbavancin didn't result in improved outcomes versus standard treatment for adults with complicated Staphylococcus aureus bacteremia. Rates of adverse events leading to ...